Trial Search Results

Efficacy of Twice Weekly Hemodialysis in Patients With Residual Kidney Function

The study will determine the efficacy of twice weekly hemodialysis in patients with residual kidney function.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Palo Alto Veterans Institute for Research

Collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Stanford Investigator(s):


  • Other: Twice weekly hemodialysis
  • Other: Thrice weekly hemodialysis




Inclusion Criteria:

   - Stable dialysis patients able to provide consent

Exclusion Criteria:

   - Use of antibiotics for last two months or expected antibiotic use

   - Recent hospitalization or other event resulting in instability of food intake

   - Residual kidney function < 2.5 mL/min

Ages Eligible for Study

18 Years - 85 Years

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305